VIVUS Initiates Avanafil Phase 3 Trials For Males With Erectile Dysfunction VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced it has initiated the first of several pivotal phase 3 studies of avanafil, our investigational product for the treatment of erectile dysfunction (ED). Avanafil is a next-generation, fast-acting, selective, investigational oral phosphodiesterase type 5 (PDE5) inhibitor.
Source: www.medicalnewstoday.comChild Abuse Causes Lifelong Changes To DNA Expression And Brain A study led by researchers in Canada who analysed post mortem brain samples of suicide victims with a history of being abused in childhood found changes in DNA expression that were not present in suicide victims with no childhood abuse history or in people who died of other causes. The affected DNA was in a gene that regulates the way the brain controls the stress response.
Source: www.medicalnewstoday.comGroundbreaking Privacy and Security Measures in President Obama's Stimulus Package to be Addressed in Mar. 11 Audioconference by Sonnenschein Nath & Rosenthal's Veteran HIPAA Attorney Reece Hirsch The economic stimulus legislation signed by President Obama on Feb. 17 contains the most significant changes to federal health care privacy and security law since the enactment of HIPAA. (PRWeb Feb 23, 2009)
Read the full story at http://www.prweb.com/releases/2009/02/prweb2137264.htm
Source: www.prweb.comBicycle Seat Design Can Directly Affect A Man's Sexual Function Long suspected by the 5 million recreational bike riders and sexual medicine experts, bicycle seat design-shorter noseless seats versus the standard protruding nose extended seat-can directly affect a man's sexual function, based on the nation's first prospective study of healthy policemen riding bikes on the job. The study is published in the current issue of the Journal of Sexual Medicine. Dr.
Source: www.medicalnewstoday.comPublication Announcement: AIS's 2009 Directory of Health Plans - Features Year-End 2008 Enrollment Data and Updated Contact Details for Key Executives Now in its 6th edition, the directory contains every health plan and primary care preferred provider network operating in the U.S. as of year-end 2008. (PRWeb Feb 23, 2009)
Read the full story at http://www.prweb.com/releases/2009/02/prweb2122694.htm
Source: www.prweb.comAdult Male Circumcision Not Linked To Sexual Dysfunction The World Health Organization recommends male circumcision as an important element in HIV prevention programs, and the procedure is promoted in high-risk heterosexual populations. While the benefits of circumcision are well-documented (they also include reduced rates of urinary tract infection, penile cancer, and cervical cancer and chlamydia in female partners), there remains a concern that adult circumcision may impair sexual function.
Source: www.medicalnewstoday.comUrologist, J. Francois Eid, M.D., Lauds Improvements In Penile Prosthesis And Artificial Urinary Sphincter Technologies Dr. J. Francois Eid has performed more internal penile implant surgeries than anyone in the world and has built a reputation for excellence in the treatment of erectile dysfunction (ED).
Source: www.medicalnewstoday.comSciele Pharma, Inc. Announce Completion Of Patient Recruitment For Global Phase III Trial Of PSD502 For Premature Ejaculation Sciele Pharma, Inc., a Shionogi company, and Plethora Solutions Holdings PLC ("Plethora," AIM: PLE), today announced the completion of patient recruitment of the PSD502 registration program for the treatment of premature ejaculation (PE). The preliminary results from this North American study are expected in mid-year 2009. A parallel European Phase III study of PSD502 concluded successfully in November 2008 with a positive outcome that was both clinically and statistically significant.
Source: www.medicalnewstoday.comPeanut Product Recall Taken Over By Texas Dept Of Health After PCA-Plainview Fails To Respond The DSHS (Texas Department of State Health Services) issued a recall order to the Peanut Corporation of America's Plainview plant - but got no response. Consequently, the DSHA says it is taking over the recall of products shipped from Peanut Corporation of America's Planview plant.
Source: www.medicalnewstoday.com
# posted by Network @ 11:58 AM
